RecruitingNCT04772768

Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Amsterdam UMC, location VUmc
Principal Investigator
Paul Knaapen, Professor
Amsterdam University Medical Centers, Department of Cardiology
Enrollment
500 target
Eligibility
18-90 years · All sexes
Timeline
2019 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04772768 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials